Startseite Crystal structure of 2-(4-fluorophenyl)-N-phenyl-2-(phenylamino)ethanesulfonamide – toluene (1/0.5), C23.5H23FN2O2S
Artikel Open Access

Crystal structure of 2-(4-fluorophenyl)-N-phenyl-2-(phenylamino)ethanesulfonamide – toluene (1/0.5), C23.5H23FN2O2S

  • Tricia Naicker EMAIL logo , Edikarlos Brasil , Marivel Samipillai , Thavendran Govender und Sooraj Baijnath
Veröffentlicht/Copyright: 20. Oktober 2018

Abstract

C23.5H23FN2O2S, Mr = 416.50, monoclinic, C2/c (no. 15), a = 27.2594(19) Å, b = 5.7351(4) Å, c = 26.1139(18) Å, β = 102.009(2)°, V = 3993.2(5) Å3, Z = 8, Rgt(F) = 0.0358, wRref(F2) = 0.0958 T = 100(2) K.

CCDC no.: 1862841

The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Needle, colorless
Size:0.31 × 0.24 × 0.13 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.20 mm−1
Diffractometer, scan mode:Bruker APEX-II, φ and ω-scans
θmax, completeness:28.4°, >99%
N(hkl)measured, N(hkl)unique, Rint:24448, 5003, 0.024
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 4259
N(param)refined:303
Programs:Bruker programs [1], SHELX [2], [3] , OLEX2 [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
S10.24347(2)0.27161(5)0.31603(2)0.01345(9)
F10.48592(3)0.36466(17)0.34266(4)0.0289(2)
O10.23132(4)0.11047(17)0.35354(4)0.0192(2)
O20.28256(4)0.21137(19)0.28887(4)0.0221(2)
N10.19352(4)0.3142(2)0.27017(4)0.0141(2)
H10.1997240.4188030.2476850.017*
N20.29754(4)0.7604(2)0.42291(4)0.0161(2)
C40.05088(5)0.4392(3)0.30282(6)0.0220(3)
H40.0188250.4682000.3104030.026*
C50.07275(5)0.6032(3)0.27569(5)0.0206(3)
H50.0551850.7425150.2637550.025*
C60.12041(5)0.5649(2)0.26581(5)0.0164(3)
H60.1357160.6787160.2478230.020*
C10.14539(5)0.3577(2)0.28262(5)0.0135(2)
C70.25712(5)0.5463(2)0.34694(5)0.0136(2)
H7A0.2667810.6564360.3215630.016*
H7B0.2263350.6073480.3566560.016*
C80.29934(5)0.5385(2)0.39625(5)0.0139(2)
H80.2919000.4105660.4195350.017*
C90.35038(5)0.4921(2)0.38311(5)0.0142(2)
C100.37608(5)0.2852(2)0.39816(5)0.0175(3)
H100.3619560.1726990.4175710.021*
C110.42224(5)0.2408(2)0.38511(6)0.0203(3)
H110.4401710.1011210.3958570.024*
C120.44100(5)0.4064(3)0.35611(5)0.0201(3)
C30.07580(5)0.2324(3)0.31893(5)0.0210(3)
H30.0605170.1195110.3371790.025*
C20.12293(5)0.1892(2)0.30855(5)0.0172(3)
H2A0.1396650.0463640.3190360.021*
C130.41688(5)0.6143(3)0.34047(5)0.0201(3)
H130.4310070.7249680.3206320.024*
C140.37137(5)0.6565(2)0.35466(5)0.0171(3)
H140.3542940.7991700.3448640.021*
C150.31376(5)0.7815(2)0.47681(5)0.0147(2)
C160.34210(5)0.6093(2)0.50747(5)0.0185(3)
H160.3504170.4694520.4917200.022*
C170.35812(5)0.6434(3)0.56124(5)0.0216(3)
H170.3767790.5243660.5819500.026*
C180.34734(5)0.8471(3)0.58494(5)0.0221(3)
H180.3591500.8699530.6214620.027*
C190.31900(5)1.0182(3)0.55462(5)0.0210(3)
H190.3112411.1584090.5706020.025*
C200.30196(5)0.9860(2)0.50136(5)0.0175(3)
H200.2821161.1031200.4812120.021*
C21a0.47069(16)0.2774(7)0.56027(14)0.0358(9)
H21Aa0.4342170.2693020.5566030.054*
H21Ba0.4802780.4356730.5521560.054*
H21Ca0.4870790.2377550.5962710.054*
C22a0.48572(13)0.1192(7)0.52562(14)0.0260(7)
C23a0.45782(15)−0.0810(8)0.50905(16)0.0254(8)
H23a0.426993−0.1053860.5197960.031*
C24a0.47410(16)−0.2460(8)0.47710(17)0.0303(8)
H24a0.454389−0.3816220.4672260.036*
C25a0.51911(15)−0.2172(8)0.4590(2)0.0327(8)
H25a0.530164−0.3277900.4367650.039*
C26a0.54637(17)−0.0139(8)0.47612(19)0.0341(9)
H26a0.5771450.0115620.4653480.041*
C27a0.53057(15)0.1526(9)0.50812(18)0.0287(9)
H27a0.5501480.2885510.5180860.034*
H20.2738(7)0.850(3)0.4086(7)0.026(5)*
  1. aOccupancy: 0.5.

Source of material

The β-amino sulfonamide title compound was obtained through the following synthetic procedure: A 10 mL single-neck round-bottom flask was charged with (E)-2-(4-fluorophenyl)ethenesulfonyl fluoride (prepared according to [11]) (0.245 mmol, 0.05 g, 1 equiv), aniline (24.5 mmol, 223 μL, 10 equiv) and DBU (50 mol%). The reaction mixture was stirred at room temperature until completion as judged by TLC analysis. The crude mixture was washed with water and extracted with Et2O (3x). The combined organic layers were washed with brine and dried over MgSO4 anhydrous. The solvent was evaporated under vacuum and the crude product was purified by column chromatography (SiO2, EtOAc/Hexane, 3:7). 1H-NMR (CDCl3, 400 MHz): δ 7.34 (2H, t, J = 7.83 Hz), 7.27 (3H, m), 7.19 (1H, t, J = 7.45 Hz), 7.12 (3H, m), 7.00 (2H, t, J = 8.56 Hz), 6.75 (1H, t, J = 7.40 Hz), 6.54 (2H, d, J = 7.84 Hz), 6.37 (1H, s), 4.94 (1H, dd, J = 3.55), 4.65 (1H, b), 3.47 (2H, m). p.p.m.

Fifteen milligram of the title compound was dissolved in 1 mL of ethanol and kept in a 5 mL vial covered with aluminium foil for the slow evaporation of the solvent at ambient condition. Single crystals were obtained after three days upon complete evaporation of the solvent which was used for the data collection at single-crystal X-ray diffractometer. The source of the residual toluene contaminant was confirmed to have come from the aniline that was used in the reaction.

Experimental details

Single colourless needle-shaped crystals of were recrystallised from ethanol by slow evaporation. A crystal was selected and mounted on a MITIGEN holder in paratone oil on a Bruker APEX-II diffractometer. Using OLEX2 the structure was solved with the SHELXS-2013 program, using the direct method. The model was refined with version 2016/6 of SHELXL.

Discussion

Novel synthetic organic compounds of potential therapeutic value and of sustainable manufacturing process are of paramount importance to pharmaceutical industries. In this context, over 100 molecules bearing the sulfonamide functional group have featured on the market as approved drugs and they are found to have a broad spectrum of biological and pharmacological activities such as antibacterials, diuretics, anticonvulsants, hypoglycemics, and as HIV protease inhibitors [5], [6] . Due to the wide range of applications of sulfonamides in medicinal chemistry, several synthetic methods for the design of new derivatives and for installing the sulfonamide functionality have been reported [7], [8] . In addition, the synthesis of transition-metal N-substituted sulfonamide complexes of iridium and osmium, for instance, has demonstrated the growing importance for asymmetric transfer hydrogenation reactions as well as in the area of cancer chemotherapy [9], [10], [11]. Hence, given the comprehensive applicability of sulfonamides, we report herein the structure characterization of the β-amino sulfonamide compound 2-(4-fluorophenyl)-N-phenyl-2-(phenylamino)ethanesulfonamide by spectroscopic and X-ray crystallography techniques.

The asymmetric unit of the crystal structure of title compound contains 2-(4-fluorophenyl)-N phenyl-2-(phenylamino)ethanesulfonamide and disordered toluene molecules. In the title compound, fluorophenyl [C9—C8—C7—S1, 69.69(12)°] and phenylamino [C15—N2—C8—C7, 152.16(11)°] moieties are attached almost perpendicular to each other. The phenyl moiety is attached to sulphonamide group from the opposite direction of fluorophenyl group with the torsion angle (C1—N1—S1—C7) of −70.12(11)°. In the crystal structure, the toluene molecules which are in disorder in a 1:1 ratio are located around a centre of inversion. The crystal structure analysis reveals that four adjacent title molecules are interconnected through C—H⋯F (C⋯F, 3.3863(18) Å and ∠C—H⋯F, 150°) and C—H⋯π (C⋯.π, 3.542(12) Å and ∠C—H⋯π, 156°) interactions, forming ternary units with molecular cavities in which the disordered toluene molecules are located. Furthermore, the molecular cavities are interconnected through N—H⋯O hydrogen bonds formed between sulphonamide and phenyl amine groups [(i) N1—H1⋯O2, 2.8998(16) Å and ∠N1—H1⋯O2, 166° and (ii) N2—H2⋯O1, 3.0348(15) Å and ∠N2—H2⋯O1, 159.6(17)°]. The overall molecular packing displays one-dimensional channels running along [100] in which the toluene guest molecules are encapsulated.

References

1. Bruker: APEX3, SAINT-Plus, XPREP. Bruker AXS Inc., Madison, WI, USA (2016).Suche in Google Scholar

2. Sheldrick, G. M.: SHELXT – Integrated space-group and crystal-structure determination. Acta Crystallogr. A71 (2015) 3–8.10.1107/S2053273314026370Suche in Google Scholar PubMed PubMed Central

3. Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Suche in Google Scholar PubMed PubMed Central

4. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H.: OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 42 (2009) 339–341.10.1107/S0021889808042726Suche in Google Scholar

5. Borhade, S. R.; Svensson, R.; Brandt, P.; Artursson, P.; Arvidsson, P. I.; Sandstrom, A.: Preclinical characterization of acyl sulfonimidamides: potential carboxylic acid bioisosteres with tunable properties. ChemMedChem 10 (2015) 455–460.10.1002/cmdc.201402497Suche in Google Scholar PubMed

6. Szafranski, K.; Slawinski, J.; Kedzia, A.; Kwapisz, E.: Syntheses of novel 4-substituted N-(5-amino-1H-1,2,4-triazol-3-yl)pyridine-3-sulfonamide derivatives with potential antifungal activity. Molecules 22 (2017) 1926.10.3390/molecules22111926Suche in Google Scholar PubMed PubMed Central

7. Chinthakindi, P. K.; Naicker, T.; Thota, N.; Govender, T.; Kruger, H. G.; Arvidsson, P. I.: Gaining momentum: sulfonimidamides in medicinal- and agrochemistry. Angew. Chem. Int. Ed. 56 (2017) 4100.10.1002/anie.201610456Suche in Google Scholar PubMed

8. Panda, N.; Yadav, S. A.; Giri, S.: Palladium-catalyzed oxidative sulfamidation: A stereoselective synthesis for enesulfonamides. Adv. Synth. Catal. 359 (2017) 654–662.10.1002/adsc.201601048Suche in Google Scholar

9. Sadler, J. P.; Wills, M.; Habtemariam, A.; Clarkson, G. J.; Sanchez-Cano, C.; Romero-Canelon, I.; Coverdale, J. P. C.: Asymmetric transfer hydrogenation by synthetic catalysts in cancer cells. Nat. Chem. 10 (2018) 347–354.10.1038/nchem.2918Suche in Google Scholar PubMed

10. Qin, H.-L.; Luo, Z.; Shang, Z.-P.; Leng, J.; Bare, G. A. L.; Zha, G.-F.: Gram-scale synthesis of β-(hetero)arylethenesulfonyl fluorides via a Pd(OAc)2 catalyzed oxidative heck process with DDQ or AgNO3 as an oxidant. Adv. Synth. Catal. 359 (2017) 1–7.10.1002/adsc.201700688Suche in Google Scholar

11. Bernhard, S.; Goldsmith, J. I.; Takada, K.; Li, M.: Iridium (III) bis-pyridine-2-sulfonamide complexes as efficient and durable catalysts for homogeneous water oxidation. Inorg. Chem. 55 (2016) 518–526.10.1021/acs.inorgchem.5b01709Suche in Google Scholar PubMed

Received: 2018-07-19
Accepted: 2018-10-08
Published Online: 2018-10-20
Published in Print: 2018-12-19

©2018 Tricia Naicker et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Artikel in diesem Heft

  1. Cover and Frontmatter
  2. Crystal structure of bis(6,6′-((ethane-1,2-diylbis(azanylylidene))bis(methanylylidene))bis(2,4-diiodophenolato)-κ4N,N′,O,O′)cer(IV), C32H20CeI8N4O4
  3. Crystal structure of (6,6′-((ethane-1,2-diylbis(azanylylidene))bis(methanylylidene))bis(2-chlorophenolato-κ2N,O))copper(II), C16H12Cl2CuN2O2
  4. Crystal structure of poly[aqua-(μ3-4-(pyridin-4-yl)isophthalato-κ4O,O′:O′′:O′′′)-(μ2-5-carboxy-2-(pyridin-4-yl)benzoato-κ2O:O′)samarium(III)], C26H18N2O9Sm
  5. Crystal structure of 1-{4-[(2-hydroxy-5-nitrobenzylidene)amino]phenyl}ethanone O-methyl oxime, C16H15N3O4
  6. Synthesis and crystal structure of bis(μ2-acetato-κ2O:O′)-bis(μ2-1-(8-(2-oxidophenyl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl)naphthalen-2-olato-κ6O:O,N,N′,O′:O′)trizinc(II), C44H38Zn3N4O12
  7. Synthesis and crystal structure of bis(μ2-acetato-κ2O:O′)–bis(μ2–(8-(2-oxidophenyl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl)naphthalen-2-olato-κ6O:O,N,N′,O′:O′)tricobalt(II), C44H38Co3N4O12
  8. Crystal structure of poly[aqua(μ4-2,2′,2′′-nitrilotriacetato-κ6O1,O3,O5:O2:O4:O6)-yttrium(III)], C6H8NO7Y
  9. Crystal structure of catena-poly[bromido-(μ2-pyrazine-2-carboxylato-κ3N:N′,O)copper(II)], C10H6N4Cu2O4Br
  10. Crystal structure of poly[dodekais(μ2-2,6-difluorobenzoato-κ2O:O′)-bis((μ3-hexamethylenetetramine-κ3N:N′:N′′)hexacopper(II)], C48H30N4O12F12Cu3
  11. Crystal structure of methyl 4-(4-hydroxy-3-nitrophenyl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C18H18N2O6
  12. Crystal structure of N-phenyl-2-(propan-2-ylidene)hydrazine-1-carbothioamide, C10H13N3S
  13. Crystal structure of sodium caesium zinc phosphate, NaCsZnP2O7
  14. Crystal structure of methyl 4-(4-isopropylphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylate, C23H29NO3
  15. Crystal structure of catena-poly[bis(μ2-1,3-di(4H-1,2,4-triazol-4-yl)benzene-κ2N:N′)-bis(thiocyanato-κ1N)cobalt(II), C22H16CoN14S2
  16. Crystal structure of catena-poly[(μ2-2,5-di(pyridin-3-yl)-1,3,4-thiadiazole-κ2N:N′)-bis(2,5-di(pyridin-3-yl)-1,3,4-thiadiazole-κ1N)-bis(thiocyanato-κ1N)cobalt(II)], C38H24CoN14S5
  17. Crystal structure of bis(2,5-di(pyridin-2-yl)-1,3,4-thiadiazole-κ2N,N′)-bis(thiocyanato-κ1N)cobalt(II), C26H16CoN10S4
  18. Crystal structure of (bis((1H-benzo[d]imidazol2-yl)methyl)amine-κ3N,N′,N′′)-(pyridine-2,6-dicarboxylato-κ3N,O,O′)zinc(II) — methanol — water (1/2/1), C25H28N6O7Zn
  19. Crystal structure of catena-poly[triaqua-(μ2-5-methoxy-isophthalato-κ2O:O′)copper(II)], C9H12CuO8
  20. Structure and photochromism of 1-[2-methyl-5-phenyl-3-thienyl]-2-[2-methyl-5-(4-chlorophenyl)-3-thienyl]3,3,4,4,5,5-hexafluorocyclopent-1-ene, C27H16ClF6S2
  21. Crystal structure of methyl 4-(3-phenoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C26H27NO4
  22. Crystal structure of poly[diaqua-di-μ2-hydroxido-(μ4-3,4,5,6-tetrafluoro-1,2-phthalato-κ4O:O′:O′′:O′′′)-(μ4-3,4,5,6-tetrafluoro-1,2-phthalato-κ5O,O:O′:O′′:O′′′)disamarium(III)] – bipyridine (2/1), C21H11NF16O12Sm2
  23. Crystal structural of diethyl 4-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, C19H21Br2NO5
  24. Crystal structure of catena-poly[tetraaqua(μ2-4-(1H-imidazol-1-yl)pyridine-κ2N:N′))zinc(II)] thiophene-2,5-dicarboxylate, C14H17N3O8ZnS
  25. Crystal structure of (20S)-20-(dimethylamino)-3-(tigloylamino)-5α-pregn-2,16-dien-4-one, C28H42N2O2
  26. Crystal structure of rac-trans-N,N′-bis(3,5-diiodosalicylidene)-1,2-cyclohexanediamine, C20H18I4N2O2
  27. Crystal structure of 2-bromo-7-(4-(dimethylamino)phenyl)-10-methylacridin-9 (10H)-one, C22H19BrN2O
  28. Crystal structure of catena-poly[(μ2-pentane-1,5-dicarboxylato-κ2O:O′)-(μ2-2-[(1H-imidazol-1-yl)methyl]-6-methyl-1H-benzimidazole-κ2N:N′)zinc(II)] sesquihydrate, C17H21N4O5.5Zn
  29. Crystal structure of ethyl 2-amino-4-(3,4-difluorophenyl)-5-oxo-4H,5H-pyrano[3,2-c] chromene-3-carboxylate, C21H15F2NO5
  30. Crystal structure of 9-(5-methylthiophen-2-yl)-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione, C18H18O3S
  31. Crystal structure of [5,5′-((propane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-2-ylidene))bis(3-(ethoxycarbonyl)-2,4-dimethylpyrrol-1-ido)-κ4N,N′,N′′,N′′′]nickel(II), C23H30N4O4Ni
  32. Crystal structure of (Z)-2-(2-(1,3-dioxo-1-(phenylamino)butan-2-ylidene)hydrazineyl) terephthalic acid-dimethylsulfoxide (1/1), C18H15N3O6 ⋅ C2H6OS
  33. Crystal structure of (2E,4Z)-dimethyl 4-((phenylamino)methylene)pent-2-enedioate, C14H15N1O4
  34. Crystal structure of (2Z,2′Z)-1,1′-(pyridine-2,6-diyl) bis(3-hydroxy-3-phenylprop-2-en-1-one), C23H17NO4
  35. Crystal structure of ethyl 2-amino-4-(3-bromophenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carboxylate, C21H16BrNO5
  36. Crystal structure of bis(μ2-3,5-dichloro-2-oxidobenzoato-κ4O,O′:O′,O′′)-hexakis(μ2-pivalato-κ2O:O′)-bis(pivalato-κ2O,O′)-tetrakis(1,10-phenanthroline-κ2N,N′)tetragadolinium(III), C102H108Cl4Gd4N8O22
  37. Crystal structure of catena-poly[aqua-bis(formato-κ1O)-(μ2-1,1′-(oxybis(1,4-phenylene))-bis(1H-1,2,4-triazole)-κ2N:N′)copper(II)]hydrate, C18H16CuN6O6
  38. Crystal structure of 5-bromo-2-(naphthalen-6-yl)pyridine, C15H10BrN
  39. Crystal structure of N-(4-methoxybenzyl)pyridazin-3-amine- a rare Z′ = 4 structure, C12H13N3O
  40. Crystal structure of bis(perchlorato-κ1O)-bis(3,4,5-trimethoxy-N-(pyridin-2-yl)benzamide-κ2N,O)copper(II), C32H30Cl2CuN4O16
  41. Crystal structure of methyl 4-methyl-2,5-di(pyridin-4-yl)-1H-pyrrole-3-carboxylate monohydrate C17H15N3O2⋅H2O
  42. Crystal structure of dimethyl 5-(10-(methoxycarbonyl)anthracen-9-yl) isophthalate,C26H20O6
  43. Crystal structure of tert-butyl (R)-(1-(benzylamino)-3-methoxy-1-oxopropan-2-yl)carbamate, C16H24N2O4
  44. Crystal structure of aqua-bis(1,5-dimethyl-2-phenyl-4-(((E)-4-pyridylmethylene)amino)pyrazolidin-3-one-κN)-(nitrato-κO)-(nitrato-κ2O,O′)zinc(II), C34H34N10O9Zn
  45. Crystal structure of catena-poly[dichlorido-(μ2-1,5-dimethyl-2-phenyl-4-((pyridin-4-ylmethylene)amino)-1,2-dihydro-3H-pyrazol-3-one-κ2N:O)cobalt(II)] – methanol (1/1), C18H20Cl2CoN4O2
  46. Crystal structure of poly[diaqua-bis(μ2-1-(4-(1H-imidazol-1-yl)benzyl)-1H-1,2,4-triazole-κ2N:N′)manganese(II)]bis(2-carboxybenzoate) dihydrate, MnC40H40N10O12
  47. The crystal structure of 4-((3,4-dichlorobenzylidene)amino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one, C18H15Cl2N3O
  48. Crystal structure of bis(2-methoxy-6-((2-(pyrimidin-2-yl)hydrazono)methyl)phenolato-κ3N,N′,O)iron(III) perchlorate, C24H22N8O8ClFe
  49. The crystal structure of 2-[4-hydroxy-3-methoxyphenyl]-4,4,5,5-tetramethylimidazoline-3-oxide-1-oxyl, C14H19N2O4
  50. Crystal structure of diaqua-bis(3,3-dimethylacrylato-κ2O,O′)zinc(II), C10H18ZnO6
  51. Crystal structure of dichloro-tetrakis[(E)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol-κN]cadmium (II), C60H74CdCl6N12O4
  52. Crystal structure of (20R)-20,25-epoxy-dammaran-3,12-dione, C30H48O3
  53. Crystal structure of (E)-3′,6′-bis(ethylamino)-2′,7′-dimethyl-2-((pyridin-2-ylmethylene)amino)spiro[isoindoline-1,9′-xanthen]-3-one, C32H31N5O2
  54. The crystal structure of 2-(4-fluorophenyl)-1,3,4-oxadiazole, C8H5FN2O
  55. Crystal structure of (2,2′-bipyridine-κ2N,N′)bis(tri(p-tolyl)phosphine-κP)copper(I) tetrafluoroborate – 4,4′-bipyridine (2/1), C57H54BCuF4N3P2
  56. The crystal structure of 2,6-dimethyl-3,5-dinitrocyclohexa-2,5-diene-1,4-dione, C8H6N2O6
  57. The crystal structure of 2,3-dimethyl-1,4-dinitrobenzene – a Z′ = 4 structure, C8H8N2O4
  58. Crystal structure of [(1,2-η)-1,2,3,4,5-pentamethyl-cyclopenta-2,4-dien-1-yl] (1,4,10,13-tetraoxa-7,16-diazacyclooctadecane-κ6N2,O4) rubidium (I), [Rb(diaza-18-crown-6)]Cp*, C22H41N2O4Rb
  59. Crystal structure of 2-(4-fluorophenyl)-N-phenyl-2-(phenylamino)ethanesulfonamide – toluene (1/0.5), C23.5H23FN2O2S
  60. Crystal structure of pyrene-4-aldehyde, C17H10O
  61. Crystal structure of 2-(furan-2-yl)-5-methyl-1,3-dioxane-5-carboxylic acid, C10H12O5
  62. Crystal structure of 2-(4-chlorophenyl)-3-phenyl-1,8-naphthyridine, C20H13N2Cl
  63. Crystal structure and photochromism of 1-(2-ethyl-5-formylthiophen-3yl)-2-(2-cyano-1,5-dimethyl-4-pyrrl)-3,3,4,4,5,5-hexafluorocyclopent-1-ene, C19H14F6N2OS
  64. Crystal structure of 2-(4-bromophenyl)-1,3-dimethyl-1H-perimidin-3-ium iodide, C19H16BrIN2
  65. Crystal structure of 2-(4-(dimethylamino)phenyl)-10-methylacridin-9(10H)-one, C22H20N2O
  66. Crystal structure of 4-(acetoxymethyl)-6-(3-acetyl-3-(4-fluorophenyl)thioureido)cyclohex-4-ene-1,2,3-triyl triacetate, C24H26FN2O9S
Heruntergeladen am 21.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2018-0253/html
Button zum nach oben scrollen